William Blair Investment Management
HAE icon

William Blair Investment Management’s Haemonetics HAE Stock Holding History

William Blair Investment Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.9M Buy
+332,075
New +$21.3M 0.07% 217
2026
Q1 		– Sell
-314,654
Closed -$25.2M – 437
2025
Q4 		$25.2M Sell
314,654
-162,056
-34% -$10.9M 0.07% 238
2025
Q3 		$23.2M Buy
476,710
+57,332
+14% +$3.55M 0.06% 274
2025
Q2 		$31.3M Sell
419,378
-6,597
-2% -$437K 0.08% 199
2025
Q1 		$27.1M Sell
425,975
-20,283
-5% -$1.38M 0.08% 240
2024
Q4 		$34.8M Buy
446,258
+101,807
+30% +$8.18M 0.09% 213
2024
Q3 		$27.7M Buy
+344,451
New +$27.8M 0.07% 255

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management's HAE Position: Q2 2026 in Review

William Blair Investment Management opened a new position in Haemonetics (HAE) in Q2 2026: 332,075 shares worth $24.9M. The stake represents 0.07% of the portfolio and ranks #217 among its holdings. This is a return to the name: William Blair Investment Management previously reported a position in HAE as recently as Q4 2025.

William Blair Investment Management first reported a position in HAE in Q3 2024 and has held it in 7 quarters since. The position peaked at $34.8M in Q4 2024. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • William Blair Investment Management held 332,075 shares of Haemonetics worth $24.9M as of Q2 2026.
  • Haemonetics was a new William Blair Investment Management position in Q2 2026.
  • Haemonetics made up 0.07% of William Blair Investment Management's portfolio in Q2 2026, its #217 holding.
  • William Blair Investment Management first reported a position in Haemonetics in Q3 2024 and has held it in 7 quarters since.
  • William Blair Investment Management's Haemonetics position peaked at $34.8M in Q4 2024.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on William Blair Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.